Articles producció científica> Medicina i Cirurgia

Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference

  • Dades identificatives

    Identificador: imarina:5878800
    Autors:
    Nicolai N, Biasoni D, Catanzaro MA, Colecchia M, Trama A, RARECAREnet Working Group
    Resum:
    © 2018 Germ-cell tumours (GCT) of the testis and penile squamous cell carcinoma (PeSCC) are a rare and a very rare uro-genital cancers, respectively. Both tumours are well defined entities in terms of management, where specific recommendations - in the form of continuously up-to-dated guide lines-are provided. Impact of these tumour is relevant. Testicular GCT affects young, healthy men at the beginning of their adult life. PeSCC affects older men, but a proportion of these patients are young and the personal consequences of the disease may be devastating. Deviation from recommended management may be a reason of a significant prognostic worsening, as proper treatment favourably impacts on these tumours, dramatically on GCT and significantly on PeSCC. RARECAREnet data may permit to analyse how survivals may vary according to geographical areas, histology and age, leading to assume that non-homogeneous health-care resources may impact the cure and definitive outcomes. In support of this hypothesis, some epidemiologic datasets and clinical findings would indicate that survival may improve when appropriate treatments are delivered, linked to a different accessibility to the best health institutions, as a consequence of geographical, cultural and economic barriers. Finally, strong clues based on epidemiological and clinical data support the hypothesis that treatment delivered at reference centres or under the aegis of a qualified multi-institutional network is associated with a better prognosis of patients with these malignancies. The ERN EURACAN represents the best current European effort to answer this clinical need.
  • Altres:

    Autor segons l'article: Nicolai N, Biasoni D, Catanzaro MA, Colecchia M, Trama A, RARECAREnet Working Group
    Departament: Medicina i Cirurgia
    Autor/s de la URV: Galceran Padrós, Jaume Josep Maria
    Paraules clau: Testicular neoplasms Tertiary care centres Survival Squamous cell Rare diseases Penis neoplasms Neoplasms Germ cell and embryonal Europe Community network Carcinoma tertiary care centres survival squamous cell rare diseases penis neoplasms neoplasms germ cell and embryonal europe community network carcinoma
    Resum: © 2018 Germ-cell tumours (GCT) of the testis and penile squamous cell carcinoma (PeSCC) are a rare and a very rare uro-genital cancers, respectively. Both tumours are well defined entities in terms of management, where specific recommendations - in the form of continuously up-to-dated guide lines-are provided. Impact of these tumour is relevant. Testicular GCT affects young, healthy men at the beginning of their adult life. PeSCC affects older men, but a proportion of these patients are young and the personal consequences of the disease may be devastating. Deviation from recommended management may be a reason of a significant prognostic worsening, as proper treatment favourably impacts on these tumours, dramatically on GCT and significantly on PeSCC. RARECAREnet data may permit to analyse how survivals may vary according to geographical areas, histology and age, leading to assume that non-homogeneous health-care resources may impact the cure and definitive outcomes. In support of this hypothesis, some epidemiologic datasets and clinical findings would indicate that survival may improve when appropriate treatments are delivered, linked to a different accessibility to the best health institutions, as a consequence of geographical, cultural and economic barriers. Finally, strong clues based on epidemiological and clinical data support the hypothesis that treatment delivered at reference centres or under the aegis of a qualified multi-institutional network is associated with a better prognosis of patients with these malignancies. The ERN EURACAN represents the best current European effort to answer this clinical need.
    Àrees temàtiques: Surgery Oncology Medicine (miscellaneous) Medicina iii Medicina ii Medicina i General medicine Enfermagem
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 07487983
    Adreça de correu electrònic de l'autor: jaumejosepmaria.galceran@urv.cat
    Data d'alta del registre: 2023-02-18
    Versió de l'article dipositat: info:eu-repo/semantics/acceptedVersion
    Enllaç font original: https://www.ejso.com/article/S0748-7983(18)30416-5/fulltext
    Referència a l'article segons font original: Ejso. 45 (1): 60-66
    Referència de l'ítem segons les normes APA: Nicolai N, Biasoni D, Catanzaro MA, Colecchia M, Trama A, RARECAREnet Working Group (2019). Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference. Ejso, 45(1), 60-66. DOI: 10.1016/j.ejso.2018.02.006
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    DOI de l'article: 10.1016/j.ejso.2018.02.006
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2019
    Tipus de publicació: Journal Publications
  • Paraules clau:

    Medicine (Miscellaneous),Oncology,Surgery
    Testicular neoplasms
    Tertiary care centres
    Survival
    Squamous cell
    Rare diseases
    Penis neoplasms
    Neoplasms
    Germ cell and embryonal
    Europe
    Community network
    Carcinoma
    tertiary care centres
    survival
    squamous cell
    rare diseases
    penis neoplasms
    neoplasms
    germ cell and embryonal
    europe
    community network
    carcinoma
    Surgery
    Oncology
    Medicine (miscellaneous)
    Medicina iii
    Medicina ii
    Medicina i
    General medicine
    Enfermagem
  • Documents:

  • Cerca a google

    Search to google scholar